Protara Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Protara Therapeutics, Inc. (TARA) reported Basic Shares Outstanding (Weighted Average) of 61.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 61.01M shares, a 44.32% increase year-over-year.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 57.54M shares, a 41.35% increase year-over-year.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 46.08M shares, a 68.51% increase year-over-year.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 42.27M shares, a 89.31% increase year-over-year.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 42.84M shares, a 108.01% increase from fiscal 2024.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 20.59M shares, a 81.73% increase from fiscal 2023.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 11.33M shares, a 0.64% increase from fiscal 2022.
- Protara Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 11.26M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 61.01M shares 10-Q · filed 2026-08-11 | 59.28M shares 10-Q · filed 2026-08-11 | 54.87M shares derived: average of 3 quarters · filed 2026-08-11 | 51.72M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 57.54M shares 10-Q · filed 2026-05-13 | 51.81M shares derived: average of 2 quarters · filed 2026-05-13 | 48.63M shares derived: average of 3 quarters · filed 2026-05-13 | 47.04M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 46.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 44.17M shares derived: average of 2 quarters · filed 2026-03-10 | 43.54M shares derived: average of 3 quarters · filed 2026-08-11 | 42.84M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 42.27M shares 10-Q · filed 2025-11-10 | 42.27M shares derived: average of 2 quarters · filed 2026-08-11 | 41.76M shares 10-Q · filed 2025-11-10 | 38.15M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 42.27M shares 10-Q · filed 2026-08-11 | 41.49M shares 10-Q · filed 2026-08-11 | 36.77M shares derived: average of 3 quarters · filed 2026-08-11 | 33.16M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 40.71M shares 10-Q · filed 2026-05-13 | 34.03M shares derived: average of 2 quarters · filed 2026-05-13 | 30.13M shares derived: average of 3 quarters · filed 2026-05-13 | 27.90M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 27.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 24.84M shares derived: average of 2 quarters · filed 2026-03-10 | 23.64M shares derived: average of 3 quarters · filed 2026-03-10 | 20.59M shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 22.33M shares 10-Q · filed 2025-11-10 | 21.78M shares derived: average of 2 quarters · filed 2025-11-10 | 18.34M shares 10-Q · filed 2025-11-10 | 16.59M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 21.23M shares 10-Q · filed 2025-08-11 | 16.33M shares 10-Q · filed 2025-08-11 | 14.67M shares derived: average of 3 quarters · filed 2025-08-11 | 13.84M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 11.42M shares 10-Q · filed 2025-05-08 | 11.39M shares derived: average of 2 quarters · filed 2025-05-08 | 11.38M shares derived: average of 3 quarters · filed 2025-05-08 | 11.36M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 11.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 11.36M shares derived: average of 2 quarters · filed 2025-03-05 | 11.34M shares derived: average of 3 quarters · filed 2025-03-05 | 11.33M shares 10-K · filed 2025-03-05 |
| 2023-09-30 | 11.35M shares 10-Q · filed 2024-11-12 | 11.33M shares derived: average of 2 quarters · filed 2024-11-12 | 11.32M shares 10-Q · filed 2024-11-12 | 11.31M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 11.31M shares 10-Q · filed 2024-08-06 | 11.31M shares 10-Q · filed 2024-08-06 | 11.29M shares derived: average of 3 quarters · filed 2024-08-06 | 11.29M shares derived: average of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | 11.30M shares 10-Q · filed 2024-05-02 | 11.29M shares derived: average of 2 quarters · filed 2024-05-02 | 11.28M shares derived: average of 3 quarters · filed 2024-05-02 | 11.27M shares derived: average of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | 11.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 11.27M shares derived: average of 2 quarters · filed 2024-03-13 | 11.26M shares derived: average of 3 quarters · filed 2024-03-13 | 11.26M shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 11.27M shares 10-Q · filed 2023-11-03 | 11.26M shares derived: average of 2 quarters · filed 2023-11-03 | 11.26M shares 10-Q · filed 2023-11-03 | |
| 2022-06-30 | 11.26M shares 10-Q · filed 2023-08-03 | 11.25M shares 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 11.25M shares 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | 11.24M shares 10-Q · filed 2022-11-03 | 11.23M shares derived: average of 2 quarters · filed 2022-11-03 | 11.23M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 11.23M shares 10-Q · filed 2022-08-09 | 11.23M shares 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 11.23M shares 10-Q · filed 2022-05-05 | |||
| 2014-12-31 | 11.44M shares 10-K · filed 2016-03-14 | 5.84M shares derived: average of 2 quarters · filed 2016-03-14 | 3.98M shares derived: average of 3 quarters · filed 2016-03-14 | 3.04M shares derived: average of 4 quarters · filed 2016-03-14 |
| 2014-09-30 | 240.61K shares 10-K · filed 2016-03-14 | 240.49K shares derived: average of 2 quarters · filed 2016-03-14 | 240.37K shares derived: average of 3 quarters · filed 2016-03-14 | 240.26K shares derived: average of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | 240.37K shares 10-K · filed 2016-03-14 | 240.26K shares derived: average of 2 quarters · filed 2016-03-14 | 240.14K shares derived: average of 3 quarters · filed 2016-03-14 | 239.97K shares derived: average of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | 240.14K shares 10-K · filed 2016-03-14 | 240.02K shares derived: average of 2 quarters · filed 2016-03-14 | 239.84K shares derived: average of 3 quarters · filed 2016-03-14 | 237.53K shares derived: average of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | 239.90K shares 10-K · filed 2015-03-20 | 239.69K shares derived: average of 2 quarters · filed 2015-03-20 | 236.66K shares derived: average of 3 quarters · filed 2015-03-20 | 235.15K shares derived: average of 4 quarters · filed 2015-03-20 |
| 2013-09-30 | 239.47K shares 10-K · filed 2015-03-20 | 235.04K shares derived: average of 2 quarters · filed 2015-03-20 | 233.56K shares derived: average of 3 quarters · filed 2015-03-20 | |
| 2013-06-30 | 230.61K shares 10-K · filed 2015-03-20 | 230.61K shares derived: average of 2 quarters · filed 2015-03-20 | ||
| 2013-03-31 | 230.61K shares 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |